2 unknown. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Unknown 2 |
Follow Myeloma, Multiple: new trials by email Literature Review of Myeloma, Multiple trials Research Report on Myeloma, Multiple
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CKD-581 + Lenalidomide + Dexamethasone in Patients With Previously Treated Multiple Myeloma Treat Regimen - Myeloma, Multiple | Phase 1 | Unknown | Chong Kun Dang Pharmaceutical | 18 | 2017-05-10 | 2020-02-24 |
| CKD-581 + Bortezomib + Dexamethasone in Patients With Previously Treated Multiple Myeloma CKD-581 - Myeloma, Multiple | Phase 1 | Unknown | Chong Kun Dang Pharmaceutical | 18 | 2017-01-01 | 2020-02-24 |
Multiple Myeloma (2)
Blood Protein Disorders (2) · Cardiovascular Diseases (2) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Hemorrhagic Disorders (2) · Hemostatic Disorders (2) · Immune System Diseases (2) · Immunoproliferative Disorders (2) · Lymphoproliferative Disorders (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms, Plasma Cell (2) · Paraproteinemias (2) · Vascular Diseases (2)
CKD-581 (1)
Chong Kun Dang Pharmaceutical (2)
South Korea (2)
Chanki Min (1) · Min Ji Song (1)